![Susan Langer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Langer
Director/Board Member at
BIOGEN INC.
Profile
Susan Langer is currently an Independent Director at Biogen, Inc. since 2023.
She is a Director at Guava Partners LLC since 2021.
She serves as a Director at NextRNA Therapeutics, Inc. since 2021.
She holds the position of President & Chief Business Officer at Soufflé Therapeutics, Inc. since 2021.
She is a Venture Partner at Old Silver VC LLC.
Formerly, Ms. Langer was President at Kojin Therapeutics, Inc. from 2020 to 2021.
She was Chief Business Officer at Paratus Sciences Corp.
from 2021 to 2023.
She was Head-Corporate Strategy at Biogen, Inc. from 2013 to 2019.
Ms. Langer completed undergraduate studies at Cornell University.
Susan Langer active positions
| Companies | Position | Start |
|---|---|---|
| BIOGEN INC. | Director/Board Member | 2023-06-25 |
NextRNA Therapeutics, Inc.
 NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Director/Board Member | 2021-03-31 |
Old Silver VC LLC
 Old Silver VC LLC Investment ManagersFinance Old Silver VC invests in companies located in the United States. The firm focuses on companies operating in the field of healthcare and material sciences. It provides financing for seed and early stage capital requirements. | Private Equity Investor | - |
Soufflé Therapeutics, Inc.
 Soufflé Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics | President | 2020-12-31 |
Former positions of Susan Langer
| Companies | Position | End |
|---|---|---|
Paratus Sciences Corp.
 Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Corporate Officer/Principal | 2022-12-31 |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | President | 2020-12-31 |
| BIOGEN INC. | Corporate Officer/Principal | 2018-12-31 |
Training of Susan Langer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | Health Technology |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology Engages in biotechnology and drug development services | Health Technology |
Old Silver VC LLC
Old Silver VC LLC Investment ManagersFinance Old Silver VC invests in companies located in the United States. The firm focuses on companies operating in the field of healthcare and material sciences. It provides financing for seed and early stage capital requirements. | Finance |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Soufflé Therapeutics, Inc.
Soufflé Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics | Health Technology |
- Stock Market
- Insiders
- Susan Langer
